Switzerland Immunoassay Analyzers Market Size & Outlook
Switzerland immunoassay analyzers market, 2016-2028 (US$M)
Related Markets
Switzerland immunoassay analyzers market highlights
- The Switzerland immunoassay analyzers market generated a revenue of USD 196.3 million in 2021 and is expected to reach USD 283.6 million by 2028.
- The Switzerland market is expected to grow at a CAGR of 5.4% from 2022 to 2028.
- In terms of segment, reagents & kits was the largest revenue generating product in 2021.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
Immunoassay analyzers market data book summary
| Market revenue in 2021 | USD 196.3 million |
| Market revenue in 2028 | USD 283.6 million |
| Growth rate | 5.4% (CAGR from 2021 to 2028) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data | 2016 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
| Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
Other key industry trends
- In terms of revenue, Switzerland accounted for 0.8% of the global immunoassay analyzers market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, UK immunoassay analyzers market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,884.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay Analyzers Market Scope
Immunoassay Analyzers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Switzerland immunoassay analyzers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.38% in 2021. Horizon Databook has segmented the Switzerland immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Switzerland has one of the most expensive healthcare systems in the world. Switzerland’s healthcare expenditure in 2018 amounted to around USD 84.4 billion or 12% of GDP. In 2017, the two most widespread causes of deaths in Switzerland were cardiovascular diseasecausing 31.4% of death and cancer causing 25.8% deaths.
While other leading causes included dementia leading to 9.8% of total deaths, and respiratory diseases leading to 6.9% of total deaths. To combat this, Switzerland adopted a National NCD prevention strategy and action plan for 2017- 2024 aiming to institute prevention work for individuals with increased risks and chronic conditions.
This plan helps improve public health literacy and build a framework promoting healthier behavior. Companies are engaged in creating advanced analyzers to combat the rising need for an accurate, timely diagnosis.
Reasons to subscribe to Switzerland immunoassay analyzers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Switzerland immunoassay analyzers market databook
-
Our clientele includes a mix of immunoassay analyzers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Switzerland immunoassay analyzers market size, by product, 2016-2028 (US$M)
Switzerland Immunoassay Analyzers Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
